Nov 4, 2026
Leaders of Scotland, Wales and Northern Ireland signed a historic agreement declaring their right to self-determination and potential departure from the United Kingdom, with all three seeing their future within the European Union.
AstraZeneca and Daiichi Sankyo are nearing a pricing agreement with the UK's National Institute for Health and Care Excellence (NICE) for their breast cancer treatment Enhertu, which could provide access to women in England and Wales with HER2-low breast cancer.